Molecular targeting: targeting angiogenesis in solid tumors.
Soria
J-C
JC
Institut Gustave Roussy, Département de Médecine, Villejuif, France.
Fayette
J
J
Armand
J-P
JP
D020533:Angiogenesis Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000503:physiopathology* / Q000628:therapy; D009389:Neovascularization, Pathologic / Q000235:genetics*; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects / Q000235:genetics / Q000502:physiology
D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A